17,500 adverse reactions reported after administration of a vaccine

17,500 adverse reactions reported after administration of a vaccine
17,500 adverse reactions reported after administration of a vaccine

With mRNA vaccines (Pfizer / BioNTech and Moderna), these side effects were more frequently reported after the administration of the second dose.
AFP (Illustration)

Since the start of the vaccination campaign in Belgium, 17,524 reports of adverse reactions have been reported after the administration of a vaccine against Covid-19, it emerges this Thursday from the weekly report of the Federal Medicines Agency and health products (FAMHP).

These figures relate to the period up to June 8 inclusive, when 5,096,646 people received at least one dose of vaccine against the coronavirus.

Of the 17,524 reports, 5,611 were registered in the European pharmacovigilance database Eudravigilance. The majority of people complained of the following symptoms: fever, muscle pain, feeling sick and reactions at the injection site. “These reactions are normal and indicate activation of the immune system. They generally disappear after a few days ”, indicates the FAMHP.

With mRNA vaccines (Pfizer / BioNTech and Moderna) these side effects were more frequently reported after administration of the second dose, whereas with Vaxzevria (AstraZeneca) they were more frequently reported with the first dose.

The FAMHP classified 3,777 reports as “serious”, due to temporary incapacity for work or the inability to leave home. One hundred and fifty-six cases have resulted in deaths, three of which are considered likely related to the vaccine. Two people died after receiving the AstraZeneca vaccine, while one person died after an injection of the Johnson & Johnson vaccine.

Adverse effects can be reported online via the form www.notifieruneffetindesirable.be

Source

adverse reactions reported administration vaccine

 
For Latest Updates Follow us on Google News
 

PREV between 5 and 10 days to report a case of COVID-19
NEXT LIVE – Deconfinement: “Tomorrow is the important step”, says Emmanuel Macron